“Burning Mouth Syndrome and Salivary Brain Derived Neurotrophic Factor Level in Type 2 Diabetes Mellitus Patients on Metformin Monotherapy and on Combination of Metformin and Glibenclamide (A Comparative Study)”. Indian Journal of Forensic Medicine & Toxicology 14, no. 2 (April 29, 2020): 2106–2112. Accessed June 7, 2026. https://medicopublication.com/index.php/ijfmt/article/view/10552.